Skip to main content
Carl Novina, MD, Oncology, Boston, MA, Dana-Farber Cancer Institute

CarlDoreNovinaMDPhD(He/Him)

Oncology • Boston, MA

Associate Professor of Medicine, Dana-Farber Cancer Institute; Harvard Medical School

Join to view full profile

Dr. Novina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Novina's full profile

Already have an account?

Summary

  • The Novina Lab studies the biology and dysregulation of non-coding RNAs and their development as biomedical tools:
    https://novinalab.dana-farber.org/

Education & Training

  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2000

Publications & Presentations

PubMed

Abstracts/Posters

  • Targeting Myeloma Cell Metabolism Via Disruption of the Lnc-17-92 Transcriptional Program: Druggable New Vulnerability in Multiple Myeloma
    Carl D. Novina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Atossa Therapeutics Appoints Dr. Paul Wabnitz to Its Scientific Advisory Board
    Atossa Therapeutics Appoints Dr. Paul Wabnitz to Its Scientific Advisory BoardAugust 18th, 2022
  • Finding Better Ways to Fight Cancer Means Starting with the Basics - Dana-Farber Cancer Institute
    Finding Better Ways to Fight Cancer Means Starting with the Basics - Dana-Farber Cancer InstituteJuly 1st, 2015

Grant Support

  • Analysis Of Cap-Dependent Translational Repression By Micrornas In OncogensisNational Cancer Institute2011
  • A B-Cell Specific Cofactor Of Nucleosome RemodelingNational Institute Of Allergy And Infectious Diseases2000–2002

Hospital Affiliations

Dr. Carl Novina, Dr. Carl Novina, MD, Dr. C Novina, Dr. Carl Dore Novina